Syndax Pharmaceuticals announced that Aaron A. Ondrey, their newly hired Chief Financial Officer effective November 9, 2026, received an inducement award to purchase up to 270,000 shares of common stock. The stock options have an exercise price of $9.55 per share, matching the closing price on the grant date, and will vest over four years contingent on Ondrey's continued employment. This award was approved by Syndax's Board of Directors under NASDAQ Listing Rule 5635(c)(4) to incentivize Ondrey's employment. Syndax continues to advance its cancer therapy pipeline, including FDA-approved drugs Revuforj and Niktimvo.
Syndax Pharmaceuticals' inducement grant news comes as 127 of 150 Health-sector US stocks tradable on Pluang rose today. For readers following the Health sector, here is Pluang's market snapshot as of Nov 10, 2026 05:21 WIB: ARWR closed at USD 49.62 with a 1-day change of -14.68%, HIMS at USD 22.26 down 14.38% but with 100% buy order activity, and TWST at USD 135.40 up 12.10% with 100% sell order activity.
The India paints and coatings market is projected to grow from $12.51 billion in 2026 to $21.17 billion by 2032, at a CAGR of 9.14%. Growth is fueled by expanding residential construction, rising demand for decorative repainting, and increased automo...
INVE Technologies has formed a strategic partnership with Trackonomy to integrate Trackonomy's Physical AI platform into INVE's acquired enterprise software products. This collaboration aims to enhance software offerings with real-world operational d...
AmpliTech Group, a company specializing in RF and microwave components for telecom and defense, will announce its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a conference call at 5:00 PM ET the...
Toll Brothers has announced the grand opening of new luxury single-story model homes at Hidden Vista, a gated community in Palm Desert, California, on November 14. These homes offer up to 2,700 sq ft with 3-4 bedrooms, modern open floor plans, and pr...
FocusReactive, a web development agency specializing in Next.js and headless CMS, achieved top rankings across six major industry review platforms in 2026, including Clutch, DesignRush, and The Manifest. The agency was recognized globally for experti...
